
京天成生物
京天成生物
Biotech/Healthcare
Jingtiancheng Biotechnology develops monoclonal antibody detection reagents. It operates platforms for antibody development and diagnostic kit development and has created tens of thousands of mouse monoclonal antibodies and rabbit and monkey polyclonal antibodies, as well as hundreds of detection…
Latest round: Series B (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.